As NAFLD is a significant risk factor for the development of MetS and T2D [60], the relation of fetuin-A to CVD is likely to be stronger in the presence of NAFLD [61]. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.